SG Americas Securities’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12K | Sell |
13,522
-49,637
| -79% | -$44.1K | ﹤0.01% | 2487 |
|
|
2025
Q1 | $29K | Sell |
63,159
-5,814
| -8% | -$2.67K | ﹤0.01% | 2929 |
|
|
2024
Q4 | $35K | Buy |
68,973
+18,053
| +35% | +$9.16K | ﹤0.01% | 2612 |
|
|
2024
Q3 | $46K | Buy |
+50,920
| New | +$46K | ﹤0.01% | 2878 |
|
|
2024
Q1 | – | Sell |
-30,889
| Closed | -$34K | – | 2805 |
|
|
2023
Q4 | $34K | Buy |
30,889
+11,779
| +62% | +$13K | ﹤0.01% | 2680 |
|
|
2023
Q3 | $23K | Buy |
+19,110
| New | +$23K | ﹤0.01% | 2710 |
|
|
2022
Q2 | – | Sell |
-12,935
| Closed | -$20K | – | 3113 |
|
|
2022
Q1 | $20K | Sell |
12,935
-18,607
| -59% | -$28.8K | ﹤0.01% | 2530 |
|
|
2021
Q4 | $77K | Sell |
31,542
-44,238
| -58% | -$108K | ﹤0.01% | 2824 |
|
|
2021
Q3 | $191K | Buy |
+75,780
| New | +$191K | ﹤0.01% | 3000 |
|
|
2021
Q1 | – | Sell |
-13,053
| Closed | -$23K | – | 2958 |
|
|
2020
Q4 | $23K | Buy |
+13,053
| New | +$23K | ﹤0.01% | 2770 |
|
|
2020
Q2 | – | Sell |
-72,784
| Closed | -$60K | – | 3201 |
|
|
2020
Q1 | $60K | Buy |
72,784
+50,733
| +230% | +$41.8K | ﹤0.01% | 2666 |
|
|
2019
Q4 | $20K | Buy |
+22,051
| New | +$20K | ﹤0.01% | 2649 |
|
|
2019
Q2 | – | Sell |
-14,574
| Closed | -$19K | – | 2717 |
|
|
2019
Q1 | $19K | Buy |
+14,574
| New | +$19K | ﹤0.01% | 2793 |
|
|
2018
Q2 | – | Sell |
-11,555
| Closed | -$27K | – | 2896 |
|
|
2018
Q1 | $27K | Sell |
11,555
-59,655
| -84% | -$139K | ﹤0.01% | 2629 |
|
|
2017
Q4 | $134K | Buy |
71,210
+57,036
| +402% | +$107K | ﹤0.01% | 2265 |
|
|
2017
Q3 | $35K | Buy |
+14,174
| New | +$35K | ﹤0.01% | 2877 |
|
|
2016
Q2 | – | Sell |
-13,179
| Closed | -$33K | – | 2331 |
|
|
2016
Q1 | $33K | Buy |
+13,179
| New | +$33K | ﹤0.01% | 2432 |
|